http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1294547-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55f8b4a24fa698ac5171923c274ca5ac |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 |
filingDate | 1987-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1992-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b898dec1e3e9fd16825e5b412540ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23235a26b81f6d9391f8b3fdeb92d653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89755c3fff048c6afc171c34dbc98939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a91381992900cbd36e3135e15e05c04 |
publicationDate | 1992-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1294547-C |
titleOfInvention | Method for treating plasma and products thereof |
abstract | METHOD FOR TREATING PLASMA AND PRODUCTS THEREOF Abstract of the Disclosure A method for treating human blood plasma which comprises passing plasma through an immunoadsorbent zone capable of binding both anti-A and anti-B blood group antibodies and removing them from the plasma. Plasma so treated may be transfused to any recipient regardless of the recipient's blood type, and it is found that such treated plasma retains substantially all other blood proteins essential for proper physio-logical activity. |
priorityDate | 1987-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.